Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells.
By M. Reyes, T. Lund, T. Lenvik, D. Aguiar, L. Koodie, C. Verfaillie. Blood, 2001
1,262 citations recorded by the source corpus.
Subfields: Genetics, Molecular Biology, Surgery
View Paper: https://www.semanticscholar.org/paper/8398c1f3736e88cd66be1c770c734f9a01ac2704
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
In Molecular Biology
In Surgery
Citations in the corpus
- Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential (2004, methodology): “One of the most successful approaches to isolate primitive cells with broad differentiation potential from adult bone marrow has utilized cells obtained after fractionation of whole bone marrow (Reyes et al., 2001; Jiang et al., 2002).”
- Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. (2005, methodology): “BMMSC-M1 and AT-MSC-M1 were isolated in the same culture medium (M1) with low serum content (2% FCS) as described by the group of Catherine Verfaillie for the isolation of MAPC [3,21].”
- Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell‐based therapy applications (2005, methodology): “To date, all previous transplantation studies have used MSCs cultured in FCS supplemented or not with growth factors (Locklin et al., 1999; Reyes et al., 2001; Bianchi et al., 2003).”
- Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy (2004, background): “cells (MAPCs) Culture-derived bone marrow-derived progenitor cells Humans [ 98 ] Murine [25] Rat [25] Table 1 Representative examples of terms given to mesenchymal stem cells.”
- In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. (2003, background): “Recently, pluripotent mesenchymal stem cells in adult bone marrow have been described that have the capacity to differentiate into mesenchymal lineage cells, endothelium (31, 32), and endoderm tissue (33) in vitro and in vivo (34).”
- Replicative Senescence of Mesenchymal Stem Cells: A Continuous and Organized Process (2008, methodology): “2 mM ascorbic acid and with medium changes every 3 to 4 days as previously described [1,53].”